V. parahaemolyticus effector modulates host metabolism by NGUYEN, QUOC ANH et al.
1 
 
Type III Secretion Effector VopQ of Vibrio parahaemolyticus Modulates Epithelial 1 










,  4 
Junko Kido
a












Department of Preventive Environment and Nutrition, Institute of Biomedical Sciences, 8 
Tokushima University Graduate School 9 
b 
Department of Food Microbiology and Molecular Biology, National Institute of Nutrition, 48 B 10 
Tang Bat Ho, Hanoi, Vietnam 11 
# Corresponding author: Takaaki Shimohata shimohata@tokushima-u.ac.jp 12 
 13 
 14 
Running title: V. parahaemolyticus effector modulates host metabolism 15 
Abstract word count: 257 words 16 
Main text word count: 4400 words 17 
Keywords: Metabolomics, host-pathogen interaction, Vibrio parahaemolyticus, T3SS effector, 18 




Vibrio parahaemolyticus is a Gram-negative halophilic pathogen that frequently causing acute 21 
gastroenteritis and occasional wound infection. V. parahaemolyticus contains several virulent 22 
factors, including Type III secretion systems (T3SSs) and thermostable direct hemolysin (TDH). 23 
In particular, T3SS1 is a potent cytotoxic inducer, and T3SS2 is essential for causing acute 24 
gastroenteritis. Although much is known about V. parahaemolyticus’s effector manipulating host 25 
signaling transductions, little is known about the host metabolomic changes modulated by V. 26 
parahaemolyticus. To address this knowledge gap, we performed a metabolomic analysis of the 27 
epithelial cells during V. parahaemolyticus infection using capillary electrophoresis–time-of-28 
flight mass spectrometry (CE-TOF/MS). Our results revealed significant metabolomic 29 
perturbations upon V. parahaemolyticus infection. Moreover, we identified that T3SS1’s VopQ 30 
effector was responsible for inducing the significant metabolic changes in the infected cells. The 31 
VopQ effector dramatically altered the host cell’s glycolytic, tricarboxylic acid cycle (TCA), 32 
amino acid metabolisms. VopQ effector disrupted host cell redox homeostasis by depleting 33 
cellular glutathione and subsequently increasing the level of reactive oxygen species (ROS) 34 
production.  35 
IMPORTANCE 36 
Metabolic response of host cells upon infection is pathogen‐specific, and the infection-induced 37 
host metabolic reprogramming may have beneficial effects on the proliferation of pathogens. V. 38 
parahaemolyticus contains a range of virulent factors to manipulate host signaling pathways and 39 
metabolic processes. In this study, we identified that T3SS1’s VopQ effector rewrites host 40 
metabolism in conjunction with the inflammation and cell death processes. Understanding how 41 
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VopQ reprograms host cell metabolism during the infection could help us to identify novel 42 






Vibrio parahaemolyticus is an aquatic Gram-negative bacterium and the causative agent of the 47 
acute gastroenteritis associated with the ingestion of raw seafood and water. Occasionally, V. 48 
parahaemolyticus causes wound infection and septicemia in immunocompromised individuals 49 
(1, 2). The pandemic strains of V. parahaemolyticus are an important public health concern, and 50 
climate change is linked to the increased incidence of V. parahaemolyticus outbreaks worldwide 51 
(3, 4). Clinical isolates of V. parahaemolyticus contain numerous virulent factors, including 52 
pore-forming thermostable direct hemolysin (TDH) toxin and two Type III secretion systems 53 
(T3SSs) that enable the delivery of bacterial effectors into the eukaryotic host (5, 6).  54 
 55 
The T3SS1 is located in an ancestral region to the bacterial first chromosome and presented in 56 
both non-pathogenic and pathogenic strains. The T3SS2 encoded genes are located on the 57 
pathogenicity islands (Vp-PAI) in the second chromosome and are associated with infectious 58 
diarrhea in humans. (7, 8, 9). T3SS1 is cytotoxic in mammalian cells, yeast and cause mortality 59 
in murine peritoneal and pulmonary infection models, whereas T3SS2 is necessary for in vivo 60 
enterotoxicity in the infant rabbit infection and mouse models (10, 11, 12, 13).  61 
 62 
To date, four effectors of T3SS1 have been identified (14, 15). In particular, the VopQ effector 63 
(VP1680 or VepA) effector has been extensively studied and is found both necessary and 64 
sufficient to induce a non-apoptotic form of cell death in vitro (16). VopQ provokes 65 
inflammatory responses through the MAPK/ERK pathway, leading to IL-8 secretion in infected 66 
Caco-2 cells (17, 18). VopQ activates NLRC3 inflammasome complexes (NOD-like receptor 67 
CARD domain-containing 3) but interferes with the activation of NLRC4 (NOD-like receptor 68 
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CARD domain-containing 4) inflammasomes in bone marrow-derived macrophages (19). 69 
Biochemical studies showed that VopQ effector disrupts lysosomal proton gradients by 70 
interacting with Vo domain of vacuolar H+-ATPase (v-ATPase) and forming an outward 71 
rectifying pores in lysosomal membrane, thus causing the release of small molecules (< 3 kDa) 72 
from the lysosomal lumen (20, 21).  Consequently, VopQ inhibits host autophagic flux by 73 
preventing lysosomal acidification and membrane fusion (22). Recently, transcriptome analysis 74 
revealed that T3SS1 activates pro-survival and suppresses cell death networks in infected human 75 
fibroblasts (23) 76 
 77 
Metabolomics, as an emerging analytical platform, has been applied to decipher host 78 
physiological perturbation and identify altered metabolic pathways during bacterial infections 79 
(24, 25). In this study, we investigated the dynamics of the metabolic processes of the epithelial 80 
cells during V. parahaemolyticus infection and the role of T3SS1’s VopQ effector in modulating 81 
host cell metabolism using capillary electrophoresis–time-of-flight mass spectrometry (CE-82 
TOF/MS). Herein, we identify that T3SS1’s cytotoxic VopQ effector is a metabolic disruptor, 83 
profoundly altering host metabolisms.  84 
 85 
Result  86 
 87 
V. parahaemolyticus infection-induced distinct metabolome alteration in the infected host cell 88 
Clinically isolated V. parahaemolyticus contains three principal identified virulent factors, 89 
including TDH toxin, and Type III secretion systems 1 (T3SS1) and Type III secretion systems 2 90 
(T3SS2), located in bacterial chromosomes 1 and 2, respectively (7). To study the metabolomic 91 
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responses of the human adenocarcinoma epithelial cell line Caco-2 to V. parahaemolyticus’s 92 
virulent factors, we infected Caco-2 cells with several V. parahaemolyticus mutant strains 93 
carrying specific virulent factors. The ∆vscN1-∆vscN2 mutant strain derived from the clinical 94 
isolate RIMD2210633 contains double deletion for genes for ∆vscN1and ∆vscN1, which are 95 
encoding structural components of the T3SS1 and T3SS2 secretion apparatus respectively. 96 
Similarly, POR2 and POR3 derived from parental POR1 strain contain double genetic deletions 97 
of tdhAS and have a deletion of vcrD1 (T3SS1) and vcrD2 (T3SS2) respectively, which encode 98 
the inner membrane structural ring for T3SS apparatus. The resulting mutant strains, ∆vscN1-99 
∆vscN2 (∆T3SS1, ∆T3SS2), POR2 (∆TDH, ∆T3SS1), and POR3 (∆TDH, ∆T3SS2), POR4 100 
(∆TDH, ∆T3SS1, ∆T3SS2) were used in our first metabolomic analysis to assess their impacts 101 
on the infected Caco-2 cell’s metabolomes. The bacterial strains and phenotypic descriptions 102 
used in this study were summarized in Table 1 and Table 2.  103 
The infections were performed at a multiplicity of 50 bacterial cells per infecting Caco-2 cell to 104 
ensure full exposure of the infected cell population, and the total metabolome was extracted at 105 
120 min post-infection to avoid excessive cytotoxicity causing leakages of cellular metabolites 106 
(Fig. S1 in the supplemental material). CE-TOF/MS identified 87 metabolites matching with the 107 
validated standards, and the changes in the relative levels of quantified metabolites upon the 108 
infections were visualized by heatmap hierarchical clustering, shown in Fig. 1A. Principal 109 
component analysis (PCA) (Fig. 1B) was performed to demonstrate further the distinct clusters 110 
of metabolites in the different infection groups. The combination of three components shown 111 
cumulatively explain 69.7% of the variation in the metabolite dataset. 112 
  113 
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To determine which host biochemical pathways were significantly altered by V. 114 
parahaemolyticus infection, we performed functional metabolite set enrichment analysis 115 
(MSEA) to identify overrepresented metabolites in the cells infected V. parahaemolyticus 116 
wildtype compared to the control group (sham infection) with human metabolite’s libraries 117 
databases using MetaboAnalyst Suite 4.0 (26). The MSEA analysis was presented according to 118 
the scores from enrichment analysis (y-axis) and topology analysis (x-axis) (Fig. 1C). The 119 
infection of Caco-2 cell with V. parahaemolyticus resulted in drastic changes in the multiple 120 
metabolites involved in glycolysis and its associated pathways, amino acid and nucleotide 121 
metabolism, and the TCA cycle metabolites (Fig. 1C). Overall, the metabolomic response to V. 122 
parahaemolyticus infection showed a strong correlation with the presence of the T3SS1 virulent 123 
factor (POR3 and WT), and the metabolic profiles of cells infected with POR4, POR2, or 124 
∆vscN1–∆vscN2 strains were more correlated with the control group. Consequently, although 125 
there was the divergence in metabolomes of cells infected with POR4, ∆vscN1–∆vscN2, and 126 
POR2 in the comparisons with the control group (sham infection) (Fig. 1B), in the context of 127 
metabolic analysis, it appeared that T3SS1 contributed the most significant metabolic 128 
perturbation observed in the infected Caco-2 cells.  129 
 130 
VopQ, a T3SS1 effector, rewrites host cell metabolomes 131 
 132 
T3SS1 translocates four identified protein effectors, including VopQ (VP1680), VopR 133 
(VP1683), VopS (VP1686), and VPA0450, working in tandem to induce autophagosome 134 
accumulation, plasma membrane blebbing, cell rounding, and eventually cell death (17, 18).  135 
Since VopQ is known to induce cell cytotoxicity and lysosomal dysfunctions, we hypothesized 136 
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that VopQ is a metabolic modifier of T3SS1 that underlies the host metabolic perturbation. Next, 137 
we constructed a V. parahaemolyticus ET4 strain derived from the parental POR3 strain, which 138 
contained only a single VopQ effector (∆VP1683, ∆VP1686, and ∆VPA0450) and S1-ENM, a 139 
V. parahaemolyticus T3SS1 effector-deficient strain (∆VP1680, ∆VP1683, ∆VP1686 and ∆ 140 
VPA0450).  141 
We performed a metabolomic analysis of Caco-2 cells infected with VopQ
+
 strains (POR3 and 142 
ET4), and S1-ENM, a VopQ deficient strain. We observed the profound metabolomic alterations 143 
at 90 post-infection in the cells infected with the T3SS1
+
 strain (POR3 and ET4) (Figure 2A). In 144 
particular, Principal component analysis (PCA) showed clear discrimination between Caco-2 145 
cells infected with the ET4 and POR3-infected cells, compared to the control (sham infection) 146 
and S1-ENM strain-infected cells. The combination of three components shown cumulatively 147 
explain 71.3 % of the variation in the metabolite dataset (Fig. 2B). Also, hierarchical cluster 148 
analysis of the infection group’s metabolite data set by Euclidean distance showed two distinct 149 
clusters I (S1-ENM and Control) and II (POR3 and ET4) (Fig. 2C). Thus, our result suggests that 150 
the T3SS1’s VopQ was responsible for the host metabolic change in Caco-2 infection model.  151 
 152 
Additionally, to monitor the onset of metabolomic changes during the infection, we performed a 153 
time-series analysis of Caco-2 cells infected with ET4 and S1-ENM strains. We observed 154 
progressively metabolomic alterations starting from 90-minutes but not initial 45-minutes post-155 
infection in ET4 strain infected cells compared to the control and S1-ENM (Fig. S2 in the 156 
supplemental material).To further confirm these results, , we analyzed the metabolomes of 157 
Human cervix carcinoma INT-407 (a HeLa derivative) cell line infected with ET4 and S1-ENM 158 
strains. Consistent with the previous metabolomic analysis results in Caco-2 cells, ET4 induced a 159 
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significant metabolomic change in INT-407 cells, and VopQ effector-deficient strain, S1-ENM, 160 
showed a metabolic pattern similar to that of the control (Fig. S3 in the supplemental material). 161 
 162 
VopQ effector repressed host cell energy metabolism 163 
Among the metabolites that were determined by the CE-TOF analytical system, we observed two 164 
to threefold increased levels of the upper glycolytic intermediates such as glucose 6-phosphate 165 
(G6P) and fructose 6-phosphate (F6P) in Caco-2 cells infected by V. parahaemolyticus POR3 166 
and ET4 strains but not with the S1-ENM strain at 90 min post-infection (p < 0.05) (Fig. 3). 167 
Interestingly, the levels of subsequent downstream glycolytic intermediates were altered in Caco-168 
2 cells infected with ET4 or POR3 compared to S1-ENM and the control. In ET4 and POR3, we 169 
found significant reductions of downstream glycolytic intermediates, including fructose 1,6-170 
phosphate (F-1,6-P), 3-phosphoglycerate (3GP), phospho(enol)pyruvic acid (PEP), and pyruvic 171 
acid (PYR) (p < 0.05) (Fig. 3), compared to Caco-2 cells infected with the S1-ENM mutant or 172 
with the control. However, we were unable to detect glyceraldehyde 3-phosphate and 2-173 
phosphoglycerate, perhaps because of their high turnover or low stability. Also, the end product 174 
of glycolysis, lactate, was lower in ET4 and POR3-infected cells compared to infection with S1-175 
ENM or the control (p < 0.05). These data suggested that V. parahaemolyticus’s VopQ effector 176 
halted glycolytic cycles in the infected cells. 177 
 178 
The accumulation of the upper and the depletion of the lower glycolytic intermediates in Caco-2 179 
cells infected with ET4 and POR3 strains implicated a bottleneck in glycolytic flux at the step 180 
catalyzed by enzyme phosphofructokinase-1 (PFK-1) that converted G6P to F-1,6-P. The 181 
accumulation of F6P and decreased downstream glycolytic metabolites in ET4 and POR3-182 
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infected cells were correlated with the increased levels of pentose phosphate pathway (PPP) 183 
intermediates such as sedoheptulose-7-phosphate, which indicated a possible metabolic reroute 184 
from glycolysis to PPP. Since, Phosphofructokinase-1 (PFK-1), a tetramer that is encoded by 185 
PFK-M (muscle), PFK-L (liver), and PFK-P (platelets), functions as the gatekeeper to glycolysis 186 
by catalyzing the phosphorylation of F6P into F1,6-P, we determined whether VopQ directly 187 
inhibits cellular PFK-1 activity in infected Caco-2 cells by enzymatic assay  (27). Unexpectedly, 188 
the PFK-1 activities of Caco-2 cells infected with POR3 and ET4 were equivalent to those of 189 
cells infected with S1-ENM, and the control indicated that VopQ indirectly inhibited PFK-1 190 
function (Fig. S4 in the supplemental material).  191 
 192 
We observed dramatic alterations of the TCA cycle’s intermediary metabolism in the infected 193 
cells with VopQ
+ 
strains (POR3 and ET4). Pyruvate, the end-product of glycolysis is converted 194 
to acetyl-CoA, was severely depleted in the infected cells with POR3 and ET4. Pyruvate 195 
contributes energy to the living cells by its conversion to acetyl-CoA, a primary fuel of the TCA 196 
cycle. Even though we observed a steeply decreased level of pyruvate, the level of acetyl-CoA 197 
was slightly reduced through it is not statistically significant in the POR3 and ET4 infected cells 198 
(Fig. 3).  Moreover, the levels of citrate, isocitrate, and succinate increased, whereas the levels of 199 
malate, fumarate, and α-ketoglutarate decreased in cells infected with VopQ
+
 strains (Fig. 3). As 200 
citrate is a potent inhibitor of phosphofructokinase-1 and the intracellular accumulation of citrate 201 
can lead to the inhibition of glycolysis and the increase of F6P and G6P level, as seen in our 202 
result (Fig. 3) (27, 28). Expectedly, the cellular nucleoside triphosphates (ATP) were decreased 203 
in conjunction with a significantly increased level of nucleoside monophosphates (AMP) (Fig. 204 
4A). To determine whether the deprivation of pyruvate is responsible for the depletion of cellular 205 
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ATP, we treated Caco-2 cells with Ethyl pyruvate (EP), a cell-permeable derivative of pyruvic 206 
acid that can be readily converted to acetyl-CoA (29). Ethyl pyruvate is an effective ROS 207 
scavenger with anti-inflammatory properties and cytoprotective (30). Administration of 5 mM 208 
(or 10 mM) ethyl pyruvate did not restore ATP level nor cytoprotective for VopQ
+
 strain 209 
infected Caco-2 cells (Fig. S7 in the supplemental material). This limited result suggested that 210 
the deprivation of pyruvate per se unlikely contributes to the reduction of cellular ATP through 211 
the TCA cycle.    212 
Since glycolysis and the oxidative phosphorylation are central ATP generating biochemical 213 
pathways in the cells. To examine the contribution of energy-generating pathways to the survival 214 
of Caco-2 cells during the infection, we pretreated Caco-2 cells with the glycolytic inhibitor 2-215 
deoxy-D-glucose (2-DG) and with rotenone, a mitochondrial respiratory chain complex I 216 
inhibitor. The result showed that inhibition of glycolysis but not mitochondrial oxidative 217 
phosphorylation sensitized Caco-2 cells to VopQ mediated cell death (Figs. 4B and C). 218 
Furthermore, Caco-2 cells cultured in glucose-free Dulbecco’s modified Eagle’s medium 219 
(DMEM) one day after reaching confluency or Caco-2 cells cultured in galactose-DMEM 220 
(glucose-free), which is known to enhance oxidative phosphorylation but to reduce glycolytic 221 
flux, showed increased susceptibility to VopQ (31, 32) (Fig. S5 in the supplemental material). In 222 
summary, our data suggested that VopQ repressed cellular energy metabolisms in Caco-2 cells 223 
preceding the cellular destruction.  224 
 225 
VopQ alters host intracellular amino acid and induced reactive oxygen species (ROS) 226 
production  227 
12 
 
Throughout V. parahaemolyticus infection, we observed significant changes in amino acid 228 
abundances in the infected cells, which were strongly associated with the presence of the VopQ 229 
effector. At 90 min post-infection, we also detected that VopQ induced increases in intracellular 230 
abundances of lysine and arginine but decreased glucogenic amino acids such as glycine, beta-231 
alanine, serine, proline, aspartate, and the two essential amino acids tryptophan and threonine 232 
(Fig. 5A). The level of alanine, a principal metabolite of pyruvate metabolism principally 233 
produced via pyruvate transamination, was also markedly reduced in cells infected with VopQ
+
 234 
strains (p < 0.05) (Fig. 5A). In addition, our metabolomic analysis indicated that the level of 235 
cellular antioxidant glutathione but not glutathione disulfide was reduced in cells infected with 236 
the VopQ
+
 effector strains compared to S1-ENM infections that lacked VopQ. The 237 
complementation of the VopQ gene on a plasmid restored the reduced glutathione (GSH)-238 
depleting phenotype of S1-ENM (Fig. 5B and 5C). This result indicated that the VopQ effector 239 
was necessary and sufficient to deplete the epithelial cell’s GSH pool. Indeed, VopQ-induced 240 
reduction of GSH was accompanied by a steep rise of cellular hydrogen peroxide (H2O2) and 241 
superoxide (O2
−
), measured by fluorescence spectroscopic assay (Figs. 5D and 5E).  242 
Since glycine and cysteine availability is the rate-determining factor in GSH biosynthesis, we 243 
tested the hypothesis that the reduction of cytosol glycine and cysteine jointly determined the 244 
glutathione synthesis rates in infected cells. The supplement of glycine or cell-permeated N-245 
acetylcysteine or both in the culture medium did not lead to the restoration of the total GSH 246 
content in ET4-strain-infected cells (Fig. S6 in the supplemental material). On the other hand, 247 
there was no GSH detected in the culture medium during the infection, indicating that GSH 248 
efflux was unlikely to be responsible for the depletion of GSH content. Taken together, our 249 
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results suggested that VopQ-induced GSH depletion and subsequently increased level of reactive 250 
oxygen species (ROS) in infected cells were independent of the variation of glycine and cysteine. 251 
 252 
Discussion 253 
In this study, we explored the metabolomic landscape of epithelial cells infected with V. 254 
parahaemolyticus. We determined that a bacterial T3SS1 effector, VopQ induces a widespread 255 
metabolic perturbation in the infected cells, profoundly altering host central carbon metabolism 256 
and amino acid metabolism. During V. parahaemolyticus infection, VopQ inhibits the activation 257 
of the host NLRC4 inflammasome but triggers the assembly of NLRC3 inflammasomes by 258 
activating caspase-1 processing of pro-IL-1b and pro-IL-18 and eventually the secretion of 259 
proinflammatory cytokines (19). Cellular metabolism plays a central role in regulating immune 260 
responses and inflammation in immune cells (33, 34). Several studies have suggested that 261 
inflammasome activation is modulated by several glycolytic enzymes (35). For example, 262 
inhibiting hexokinase-1 or pyruvate kinase (PKM2) suppresses NLRP3 inflammasome activation 263 
in macrophages (36, 37). While other studies reported inhibition of the glycolytic enzymes by 2-264 
deoxyglucose (2‐DG) treatment, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and α-265 
enolase can trigger NLRP3 inflammasome activation (38, 39). These contracting results illustrate 266 
the mechanistic complexity and plasticity of cellular metabolism. In Salmonella-infected 267 
macrophages, cellular glycolysis is diminished because of the uptake of host cell glucose by 268 
Salmonella in conjunction with SPI-1 T3SS-dependent NLRP3 activation (40). Mechanistically, 269 
Salmonella typhimurium mutant strain lacking the TCA enzyme aconitase induced rapid NLRP3 270 
inflammasome activation by inducing bacterium-derived citrate accumulation, leading to the 271 
upstream accumulation of F6P and G6P (40). Our results implicated that the VopQ-mediated 272 
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inhibition of host cell glycolysis may be linked to the activation of NLRC3 inflammasomes in 273 
macrophages (19). In addition, our results showed that the decrease in glycolysis flux increased 274 
the sensitivity to VopQ-mediated cell death. These findings suggest that VopQ effector 275 
interfering with cellular energy metabolism and the survival of the host cells.  276 
 277 
Cells infected with VopQ showed decreased amino acid metabolism, including several 278 
nonessential amino acids and some metabolites involved in the anabolic pathways of these amino 279 
acids. Amino acids play a pivotal role in regulating physiology and cell proliferation. 280 
Consequently, the variation in cellular amino acid metabolism could substantially influence the 281 
outcome of an infection. Indeed, bacterial, parasitical, and viral infections have been associated 282 
with significant metabolic alterations in mammalian hosts (41, 42). For instance, 283 
enterotoxigenic Escherichia coli (ETEC) infection decreases isoleucine level in piglet serum and 284 
reduces the concentration of nonessential amino acids, including glutamine, asparagine, 285 
citrulline, and ornithine, but increases the levels of glycine and GABA (43). During invasive 286 
Salmonella or Shigella infections, the epithelial cell’s intracellular amino acids were acutely 287 
depleted, leading to the inhibition of mTOR activity and the activation of autophagy (44). 288 
Indeed, VopQ is capable of rapidly induce autophagy in both phagocytic and non-phagocytic 289 
cells (19, 45). 290 
The alteration of the intracellular amino acids induced by VopQ can be a result of changes in 291 
either amino acid metabolism or amino acid transport or both. Glycolysis and the TCA cycle 292 
both provide indispensable carbon skeletons, including 3-phosphoglyceric acid, pyruvic acid, 293 
and α-ketoglutarate, for the biosynthesis of nonessential amino acids. Through a cascade of 294 
enzymatic reactions, chiefly transaminases and aminotransferases, these carbon donors are 295 
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converted into corresponding amino acids: serine, glycine, and cysteine (3-phosphoglyceric 296 
acid); alanine (pyruvic acid); and aspartic acid and glutamic acid (α-ketoglutarate) (46). 297 
Therefore, the de novo biosynthesis of amino acids strictly requires the availability of a carbon 298 
donor or a structurally related amino acid. The decreased level of nonessential amino acids in 299 
infection with VopQ
+
 strains is consistent with the severe depletion of glycolytic and the TCA 300 
cycle’s intermediates, namely, 3-phosphoglyceric acid, pyruvic acid, and α-ketoglutarate. 301 
Although we cannot exclude the possibility that VopQ can alter the rate of amino acid transport 302 
in the infected cells, it is likely that the reduction of nonessential amino acids induced by VopQ 303 
was due to a lack of carbon donor precursors.  304 
Another important finding in our study is that VopQ depletes the host’s cellular glutathione and 305 
induces oxidative stress. Glutathione is a tripeptide, consisting of glycine, cysteine, and 306 
glutamate that participates in many critical cellular functions in mammalian cells (47, 48). 307 
Glutathione is predominantly found in the cytosol mainly in the reduced state (GSH) and less 308 
often in its oxidized state, glutathione disulfide (GSSG). Together with other antioxidant 309 
enzymes, the GSH/GSSG redox system safeguards the cellular oxidative balance (49). GSH 310 
plays a major role in the removal of many reactive species such as superoxide (O2
−
) and 311 
hydrogen peroxide (H2O2) through GSH peroxidase oxidization of GSH to GSSG and H2O. The 312 
depletion of GSH is a marker of a disease’s associated pathological state and the development of 313 
destructive cellular processes such as apoptosis and necrosis (50). 314 
Our study has several limitations. First, we measured the abundance of selected metabolites, and 315 
therefore, we only captured a metabolomic snapshot at a given time of sampling, but not the 316 
metabolic turnover rate, which represents the dynamic status of cellular biochemical processes. 317 
Consequently, we were unable to elucidate the exact metabolic flux of host cells’ responses to V. 318 
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parahaemolyticus infection. Second, our study used Caco-2 and INT-407 cell lines, which are 319 
established cancer cell lines, as the infected host cells. Those cell lines are known to be 320 
metabolically altered to favor glycolytic metabolism over oxidative phosphorylation, even in the 321 
aerobic conditions. Thus, this inherent metabolic abnormality can mask pathogen-induced host 322 
interaction. Additional studies with other primary cells are warranted to confirm further the 323 
general relevance of these metabolomic patterns observed in Caco-2 cells. In summary, we 324 
identified that the V. parahaemolyticus VopQ effector subverted Caco-2 cells’ energy 325 
metabolism, amino acid balance, and redox hemostasis. Boosting the cellular bioenergetic state 326 
can be a promising target to enhance cellular survival during V. parahaemolyticus infection.  327 
Material and methods 328 
Bacterial strains and culture conditions 329 
V. parahaemolyticus strain RIMD2210633 (KP-positive, serotype O3: K6) was used as the 330 
standard strain. The bacteria were cultured in Luria–Bertani (LB) medium supplemented with 331 
3% NaCl at 37°C. For the construction of deletion mutants, Escherichia coli DH5α and 332 
SM10λpir strains were used to mobilize plasmids into V. parahaemolyticus. Escherichia coli 333 
strains were cultured in LB medium supplemented with antibiotics at the following 334 
concentrations with shaking at 37°C: kanamycin, 50 μg mL
−1
, and chloramphenicol, 20 μg mL
−1
. 335 
Strains and constructed plasmids used in this study are presented in Table S1 in the supplemental 336 
material.  337 
Construction of deletion mutants  338 
Deletions of mutant strains were constructed by a two-step allelic exchange method using POR3 339 
as the parental strain, as previously described (51). Briefly, approximately 400–500 nucleotide 340 
fragments of DNA regions upstream and downstream of the targeted gene were amplified by 341 
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polymerase chain reaction (PCR) using the primers listed in Table S1 in the supplemental 342 
material. Primers 2 and 3 contained a 15–18 bp overlapped site to connect the 3’ end of the 343 
upstream fragment with the 5′  end of the downstream fragment. Two amplified DNA 344 
fragments were joint by the second round of overlapping PCR using primers 1 and 4. The 345 
amplified fragment was cloned into Blunt End TOPO Cloning (Thermo Fisher Scientific) and 346 
propagated in E. coli DH5α. The inserted fragment containing a deletion cassette was excised by 347 
restriction digestion with BamHI and PstI and subcloned into the suicide vector pYAK1. The 348 
constructed plasmid was introduced into E. coli strain SM10λpir and was mobilized into the V. 349 
parahaemolyticus POR3 strain by conjugation. The crossing-over colonies were selected by 350 
counterselection on 10% sucrose TCBS. Isolates with deletion allele were confirmed by PCR and 351 
sequencing.  352 
Complementation of deleted genes 353 
Complementation of deleted genes was carried out as previously described (51). Briefly, the 354 
VP1680 coding region of VopQ was amplified by PCR and was subsequently cloned into 355 
pSA19CP-MCS, and the plasmid construct was introduced into the deletion mutant strains by 356 
electroporation. 357 
Cell culture 358 
Caco-2 cells and INT-407 cells were cultured in DMEM (Sigma-Aldrich) supplemented with 359 
10% fetal bovine serum (Gibco BRL) and 50 μg/mL gentamicin (Sigma-Aldrich). Caco-2 cells 360 
and INT-407 cells were seeded at 4 × 10
5
 and 8 × 10
5
 cells/well, respectively, in a 6-cm cell 361 
culture plate. The cells were maintained at 37°C in a humidified atmosphere of 5% CO2. Caco-2 362 




Infection protocol  365 
The culture medium was replaced with fresh DMEM (without supplements) at 2 hours before 366 
infection. For the first metabolomics analysis (result in figure 1), after overnight cultivation, 367 
bacteria were harvested by centrifugation at 6,000 rpm at room temperature and were 368 
resuspended in phosphate-buffered saline (PBS) and adjusted to an OD600 of 1.0. Bacteria were 369 
inoculated into the mammalian cells at a multiplicity of infection (MOI) of 50 bacterial cells to 370 
one Caco-2 cell (50:1), and the infections were allowed to proceed at 37°C in 5% CO2 at each 371 
different time point.  372 
For the second metabolomics analysis (result in Figure 2), to ensure the uniform expression of 373 
VP T3SS1, overnight cultured bacteria were inoculated in DMEM in a humidified atmosphere 374 
containing 5% CO2 at 37°C for 6 h before starting the experiment. Other subsequent steps were 375 
the same as described in the above text.  376 
Metabolite extraction and CE-TOF/MS analysis 377 
Cells were collected for metabolome analysis at indicated infection times. Approximately 2.5 × 378 
10
6
 cells were infected with each V. parahaemolyticus strain at each given time point, with MOI 379 
50:1. The supernatant was removed, and cells were washed twice with 5 mL of cold 5% mannitol 380 
solution. Metabolic activity was rapidly quenched by adding 0.5 mL methanol containing 381 
internal standards (100 µM methionine sulfone and camphor 10-sulfonic acid). Intracellular 382 
metabolites were extracted using a solvent extraction method by mixing homogenates with 400 383 
µL chloroform and 200 µL Milli-Q water. The mixture was centrifuged (5000 rpm, 4°C, 5 min). 384 
Subsequently, the aqueous layer was filtered using 5-kDa cut-off filters (Millipore, Bedford, 385 
MA) and centrifuged (10,000 rpm, 4°C, 6 h). The filtrate was dried using a vacuum evaporator 386 
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(4000 rpm, 4°C, 4 h) and reconstituted in 50 µL Milli-Q water containing spiked internal 387 
standards (25 mM each of 3-aminopyrrolidine and trimesic acid) before analysis.  388 
CE-TOF/MS was performed using an Agilent CE Capillary Electrophoresis System coupled with 389 
an Agilent 6210 Time-of-Flight mass spectrometer (Agilent Technologies, Palo Alto, CA) as 390 
described by Human Metabolome Technologies, Inc. (HMT, Tsuruoka, Japan) (52).  391 
Bacterial metabolite contamination testing 392 
Since V. parahaemolyticus can adhere to the host cell surface during the coculture mammalian 393 
period, thus bacterially derived metabolites can be co-extracted with the host’s metabolites. We 394 
determined that after two washing cycles with 5 mL of 5% mannitol solution, the number of V. 395 
parahaemolyticus adhered in Caco-2 cells was approximately 1 × 10
5
 bacterial cells per sample. 396 
Still, we were unable to detect significant bacteria-derived metabolites in 1 × 10
7
 bacterial 397 
cells/mL in our CE-TOF/MS analysis. It suggests that bacterial-derived metabolite 398 
contamination was negligible comparing to host-derived metabolites. 399 
Data processing, normalization, and statistical analysis 400 
Data processing was conducted using Mass Hunter software (Agilent Technologies, Palo Alto, 401 
CA). Metabolites are identified by matching their normalized migration times and accurate m/z 402 
values for each peak to the mixture of standard compounds (Human Metabolome Technologies, 403 
Inc. HMT, Tsuruoka, Japan). Metabolite’s peak area values were normalized by median 404 
centering. Missing values were replaced by the lowest value detected for that specific metabolite. 405 
Statistical analysis of fold changes by two-way ANOVA and Dunnett’s multiple comparison 406 
tests were used to determine metabolites with a significant alteration (p ≤ 0.05) for each group of 407 
samples infected by a different V. parahaemolyticus strain. Statistical analysis was performed 408 
using GraphPad Prism 8 (GraphPad Software, USA). Multivariate statistical analysis, 409 
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hierarchical clustering by heatmap and PCA of metabolite’s dataset were computed using the 410 
Web-based MetaboAnalyst suite (26). Metabolite Set Enrichment Analysis (MSEA) was 411 
performed using MetaboAnalyst 4.0. Data for metabolites detected in each sample groups were 412 
input into MSEA with annotation based on standard chemical names. Metabolites were 413 
confirmed manually using Human Metabolome Database (HMDB) and human reference 414 
pathway library was used for the pathway enrichment analysis (KEGG Database). 415 
 416 
Cytotoxicity assay 417 
The cytotoxicity assay used a quantitative measurement of lactate dehydrogenase (LDH) release 418 
in the culture medium. In brief, the supernatants of infected cells or treatments were collected at 419 
corresponding post-infection points, and lactate dehydrogenase (LDH) release was measured 420 
with a Non-Radioactive Cytotoxicity Assay (Promega, Madison, WI) according to the 421 
manufacturer’s manual. Fifty microliters of cell culture supernatant were transferred into a 422 
transparent 96-well plate, and 50 μL of assay buffer was added and then incubated at room 423 
temperature in the dark for 30 min. The reaction was stopped by the addition of 50 μL of 1 M 424 
stop buffer. LDH release was quantified by measuring absorbance at 490 nm.  425 
Glutathione measurement  426 
Total glutathione was determined using a Glutathione Quantification Kit (Dojindo Molecular 427 
Technologies, Inc.) according to the manufacturer’s instructions. In brief, in six-well plates, 428 
Caco-2 cells infected with V. parahaemolyticus strains were washed twice with 2 mL of PBS. 429 
The cells were then lysed by the addition of 300 µL of 10 mM HCl and then frozen and thawed 430 
twice, and then, the samples were centrifuged at 12,000 rpm for 10 min. The supernatant was 431 
used for a GSH assay, and the absorbance at 405 nm was measured.  432 
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Reactive oxygen species measurement 433 
Cells (10
4
/well) were seeded in 96-well plates for 4 days. Cells were infected with different 434 
strains of V. parahaemolyticus for respective periods with an MOI of 50:1. After removal of the 435 
culture medium, the level of hydroperoxide was measured by incubating with 5 µM BES-H2O2-436 
AM and 2.5 µM Bes-SO-AM (Wako Chemicals, Osaka, Japan) at 37°C for 1 h. After washing 437 
twice with PBS, the BES-H2O2-AM and Bes-SO-AM fluorescent signals were detected at 438 
excitation/emission wavelengths of 485/530 and 505/544 nm, respectively.  439 
PFK activity measurement  440 
The phosphofructokinase activity was measured using the phosphofructokinase (PFK) Activity 441 
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Table 1. Strains and plasmids used in this study 610 
Strains or plasmid Genotype Description  Source or 
reference 
V. parahaemolyticus strains  
RIMD2210633 Wildtype  Clinical isolate; KP positive, serotype O3: K6 (8) 
    
vscN1-vscN2 ∆ vscN1, ∆ vscN2 T3SS1 and T3SS2 deficient strain: vscN1 and 
vscN2 encoding a cytoplasmic protein of the 
TTSS apparatus deletion mutant derived from 
Wildtype strain 
(51) 
    
POR2 ∆ tdhAS, ∆ vscD1 TDH toxin and T3SS1 deficient strain: vcrD1 
needle apparatus gene deletion from POR-1 
strain 
(51) 
POR3 ∆ tdhAS, ∆ vscD2 TDH toxin and T3SS2 deficient strain: vcrD2 
needle apparatus gene deletion derived from 
POR-1 strain 
(51) 
POR4 ∆ tdhAS, ∆ vcrD1, ∆ vcrD2 TDH toxin, T3SS1 and T3SS2 deficient mutant 
derived from POR-1 in which the T3SS1 needle 
apparatus gene (vcrD1) and T3SS2 needle 
apparatus gene (vcrD2) were deleted  
(52) 
ET4 ∆ tdhAS, ∆ vscD2, ∆VP1683, 
∆VP1686, ∆VPA0450 
VP1680 containing strain - mutant strain deleted 
other T3SS1 effectors: ∆VP1683, ∆VP1686, 
∆VPA0450 derived from POR-3 strain 
This study 
S1-ENM ∆ tdhAS, ∆ vscD2, ∆VP1680, 
∆VP1683, ∆VP1686, 
∆VPA0450 
T3SS1 effector deficient strain, mutant strain 
deleted all T3SS1 effectors: ∆VP1680, 
∆VP1683, ∆VP1686, ∆VPA0450 derived from 
POR-3 strain 
This study 
    
E. coli 
 




thi thr leu tonA lacY supE 
recA::RP4-2Tc::Mu λpir R6K 
 













 R6K-ori suicide vector, containing sacB gene 
for counterselection, Cmr 
 






pSA-vp1680  Complement vector, expressing the open 
reading frame of vp1680 gene controlled by a 
tdhA promoter Cmr 
This study 




Table 2.  The phenotype of V. parahaemolyticus strains derived from the RIMD2210633 613 
clinical isolate used in this study 614 
 615 
Strain TDH T3SS1 T3SS2 
  VopQ VopR VopS VPA0450  
RIMD2210633 + + + + + + 
vscN1-vscN2 + - - - - - 
POR2 - - - - - + 
POR3 - + + + + - 
POR4 - - - - - - 
ET4 - + - - - - 
S1-ENM - - - - - - 
 616 
 617 
  618 
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Figure Legends 619 
 620 
Figure 1. Multivariate analyses revealed a specific signature for Vibrio parahaemolyticus 621 
infection associated with T3SS1. Metabolites were extracted from Caco-2 cells infected with 622 
different V. parahaemolyticus strains at 120 min post-infection (MOI = 50:1; n = 4). (A) 623 
Heatmap and hierarchical clustering of Caco-2 metabolomes according to the infection strains 624 
and metabolite abundances showing the differences and similarities of Caco-2 cells metabolic 625 
states when infected with V. parahaemolyticus strains.  The metabolite abundances were scaled 626 
on a range of −1.5 to 1.5 and clustered according to Euclidean distance. (B) Three-dimensional 627 
(3D) principal component analysis (PCA) score plots showed distinct clusterization of Caco-2 628 
cell metabolites infected with the control group (sham infection); POR4, ∆vscN1-∆vscN2; 629 
POR2; POR3; and wild type (WT). (C) Metabolite set enrichment analysis (MSEA) showed 20 630 
significantly enriched biological pathways (p < 0.05) associated with V. parahaemolyticus 631 
infection. Color intensity (white to red) indicates the increasing statistical significance of 632 
pathway enrichment analysis. The graph was plotted on the y-axis showed the −log of p-values 633 
from pathway enrichment analysis and on the x-axis from pathway topology analysis. 634 
 635 
Figure 2. Multivariate analyses showed a specific metabolic signature associated with VopQ. 636 
Metabolite extracted from Caco-2 cells infected with different S1-ENM and ET4 strains at 90 637 
post-infection (MOI = 50:1; n = 4). (A) Heatmap and hierarchical clustering of Caco-2 638 
metabolomes according to the infection strains and metabolite abundances showing the 639 
similarities of Caco-2 cells metabolic states when infected with POR3 and ET4 strains compared 640 
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to S1-ENM and control.  The metabolite abundances were scaled on a range of −1.5 to 1.5 and 641 
clustered according to Euclidean distance. (B) Three-dimensional (3D) principal component 642 
analysis (PCA) score plots showed distinct clusterization of Caco-2 cell metabolites infected 643 
with POR3 and ET4 compared with the control group (sham infection) and S1-ENM. (C) 644 
Hierarchical clustering analysis was performed according to Euclidean distance between the 645 
control group (sham infection); POR3, ET4, and S1-ENM showed two district clusterization.  646 
 647 
Figure 3. VopQ rerouted Caco-2 cell metabolites from glycolysis to PPP metabolites. The 648 
relative abundances of glycolytic and PPP metabolites of Caco-2 cells infected with different V. 649 
parahaemolyticus mutants extracted 90 min post-infection. Mean ± SD is shown for 4 biological 650 
replicates. One-way ANOVA with Dunnett’s multiple comparison test was applied to the S1-651 
ENM, ET4, and POR3 groups for comparison to the control group (*p < 0.05; **p < 0.01). The 652 
y-axis represents the relative ambulance in peak intensity (concentration) of the identified 653 
metabolites.  The black, blue, and highlighted blue letters represent the metabolic intermediates 654 
from glycolysis, pentose phosphate pathway, and TCA cycle, respectively. The green and orange 655 
letters signify enzymes and co-factors that catalyze the corresponding metabolic pathways. 656 
 657 
Figure 4. VopQ disrupted cellular biogenetics. (A) The relative abundances of ATP, ADP, and 658 
AMP metabolites of Caco-2 cells infected with different V. parahaemolyticus mutants measured 659 
by CE-MS at 90 min post-infection. Mean ± SD is shown for four biological replicates. One-way 660 
ANOVA with Dunnett’s multiple comparison test was applied to S1-ENM, ET4, and POR3 661 
groups for comparisons to the control group (*p < 0.05; **p < 0.01). Caco-2 cell cytotoxicity at 662 
4 h with different V. parahaemolyticus mutants measured by LDH release assay. Caco-2 cells 663 
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were treated with (B) 25 mM of 2-deoxyglucose (2-DG) and (C) 50 nM rotenone. Statistical 664 
analysis by Student’s t-test (*p < 0.05 or **p < 0.01) with mean ± SD shown for three biological 665 
replicates.  666 
 667 
Figure 5. VopQ disrupted cellular amino acid hemostasis. (A) The percent relative abundances 668 
of amino acids of Caco-2 cells infected with different V. parahaemolyticus mutants measured by 669 
CE-MS at 90 min post-infection. Mean ± SD shown for four biological replicates. One-way 670 
ANOVA with Dunnett’s multiple comparison test was applied to the S1-ENM, ET4, and POR3 671 
groups for comparisons to the control group (*p < 0.05 or **p < 0.01). (B), (C) Cellular 672 
glutathione and glutathione disulfide (GSSG) concentration of Caco-2 cells infected with 673 
different V. parahaemolyticus mutants for 2 h. (D), (E) Relative level of hydrogen peroxide 674 
(H2O2) and superoxide (O2
−
) of Caco-2 cells infected with different V. parahaemolyticus mutants 675 
for 2 h. Statistical analysis by One-way ANOVA with Dunnett’s multiple comparison test was 676 
applied to the S1-ENM, ET4, and POR3 groups for comparisons to the control group for 4 677 
biological replications (*p < 0.05 or **p < 0.01).  678 
 679 
  680 
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Supplemental Material 681 
 682 
Table S1. Primers list used in this study 683 
 684 
Figure S1. (A) Metabolomics analysis workflow of Caco-2 cells infected with Vibrio 685 
parahaemolyticus strains. (B) Cytotoxic activity (% LDH release) of Caco-2 cells infected with 686 
different Vibrio parahaemolyticus strains for WT or the isogenic mutants at a multiplicity of 687 
infection (MOI) = 50:1 at 3-hour post-infection. (C) Cell viability (Trypan blue exclusion 688 
staining) of Caco-2 cells infected with different Vibrio parahaemolyticus strains for WT or the 689 
isogenic mutants at a multiplicity of infection (MOI) = 50:1 at 3-hour post-infection. The strains 690 
tested were WT (RIMD2210633), POR2 (∆ tdhAS, ∆ vscD1), POR3(∆ tdhAS, ∆ vscD2), vscN1-691 
vscN2 (∆vscN1-∆vscN2) and POR4 (∆ tdhAS, ∆ vscD1, ∆ vscD2). The error bars indicate 692 
standard deviations from triplicate samples (n=3). 693 
 694 
Figure S2. Multivariate analyses showed a specific metabolic signature associated with VopQ. 695 
Metabolite extracted from Caco-2 cells infected with different S1-ENM and ET4 strains at 45-696 
minute, 90 minute and 150-minute post-infection (MOI = 50; n = 3). Heatmap and hierarchical 697 
clustering of Caco-2 metabolomes according to the metabolite abundances between control 698 
(sham infection); S1-ENM and ET4, showing the differences and similarities of the Caco-2 cells 699 
metabolic pattern at different time points.  The metabolite abundances were scaled in a range of 700 




Figure S3. Multivariate analyses showed the VP1680 effector repressed INT-407 cells central 703 
metabolism. Metabolite extracted from INT-407 cells infected with different V. 704 
parahaemolyticus strains at 90-min post-infection (MOI = 10:1; n = 4). Heatmap represented 705 
hierarchical clustering analysis with significantly relative metabolite abundances between control 706 
(sham infection), S1-ENM, and ET4. The metabolite abundances were scaled in a range of − 3 to 707 
3 and clustered according to the Euclidean distance matrix. 708 
 709 
Figure S4.  Relative phosphofructokinase activities of Caco-2 cell infected with POR3, ET4, S1-710 
ENM strains, and control extracted at 2-hour post-infection. No significant difference detected 711 
by One-way ANOVA with Dunnett’s multiple comparison test was applied to the S1-ENM, ET4, 712 
and POR3 groups for comparison to the control group (n = 4). 713 
 714 
Figure S5. Caco-2 cells were cultured in the high glucose medium DMEM (4.5 mg/l glucose) 715 
for 4 days. For glucose-free medium culture, cells after reaching the confluence medium contain 716 
glucose were replaced with Glucose free DMEM medium for 1 day before the experiment. For 717 
the galactose medium culture, Caco-2 cells were cultured in galactose medium for 4 passages in 718 
20 days. The fifth cell passage was selected for the experiment. Cytotoxicity of Caco-2 cells 719 
infected with different V. parahaemolyticus strains with treatments: 4.5 g/ml DMEM medium, 720 
glucose-free medium, 4.5 mg/l galactose medium for 4 hours. Mean ± SD shown for 4 biological 721 





Figure S6. Effects of Glycine and NAC on the GSH level. Caco-2 cells were incubated with 0.5 725 
mmol/l Glycine or/and 0.5 mmol/l NAC for 8 hours prior to starting an infection. GSH content 726 
was measured by colorimetric assay at 3 hour-post infections. Results were expressed as mean, 727 
and SD were calculated from 4 biological replications. No significant differences found by One-728 
way ANOVA with Dunnett’s multiple comparison test between treatments with ET4 infection.  729 
 730 
Figure S7. Effects of ethyl pyruvate on ATP level and cell cytotoxicity on Caco-2 cells. Caco-2 731 
cells were incubated with 5 mM and 10 mM of Ethyl pyruvate for 2 hours before and 732 
continuously during the infection (MOI) = 50:1 with POR3. (A) Cellular ATP content was 733 
measured by a luciferase assay at 2 hour-post-infections. (B)  Cytotoxic activity (% LDH 734 
release) of Caco-2 cells at 6-hour post-infection. Results were expressed as mean, and SD was 735 
calculated from 4 biological replications. No significant differences found by One-way ANOVA 736 
with Dunnett’s multiple comparison test between treatments with POR3 infection. 737 
 738 





